Eli Lilly could launch obesity drug in India next year, CEO says

 U.S. drugmaker Eli Lilly (LLY.N), opens new tab expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after it clears an ongoing regulatory review, CEO David Ricks told Reuters on Wednesday.